Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoride Supplementation in Pregnancy
NCT02536352Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2015
- Primary completion
- Oct 2019
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fluoride in preterm birth, Preterm labor (PTL), preterm premature rupture of membranes (pPROM) and 1 more (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Length of gestation up to 30 weeks. Started Oct 2015; status: completed.
02
Drugs
fluoride
03
Conditions
preterm birthPreterm labor (PTL)preterm premature rupture of membranes (pPROM)Bacteremia
Beyond the preview
Go deeper on NCT02536352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02536352.